Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 25;12(6):958.
doi: 10.3390/antibiotics12060958.

The Antimicrobial Applications of Nanoparticles in Veterinary Medicine: A Comprehensive Review

Affiliations
Review

The Antimicrobial Applications of Nanoparticles in Veterinary Medicine: A Comprehensive Review

Mariana Paiva Rodrigues et al. Antibiotics (Basel). .

Abstract

Nanoparticles (NPs) are nanoscaled particles sized from 1-100 nm, which can be composed of inorganic or organic compounds. NPs have distinctive morphology, size, structure, and surface features, which give them specific properties. These particular attributes make them interesting for biological and medical applications. Due to these characteristics, researchers are studying the possible aptness of numerous nanoparticles in veterinary medicine, such as the capacity to act as a drug delivery system. The use of these NPs as a possible bactericidal or bacteriostatic medication has been studied against different bacteria, especially multiresistant strains and the ones that cause mastitis disease. The antibiofilm property of these nanostructures has also already been proved. The antiviral activity has also been shown for some important viral animal diseases; the antifungal activity had been demonstrated against both pathogenic and mycotoxigenic species. Therefore, this review aimed to elucidate the main clinical and preventive veterinary applications of inorganic and organic nanoparticles.

Keywords: antibiofilm; antimicrobial; antimycotoxin; drug delivery system; nanostructures.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Document count of scholarly works from 2013 to 2023 obtained using the key words “nanoparticles AND veterinary” in the Lens.org database (accessed on 17 May 2023).
Figure 2
Figure 2
Word cloud showing the 50 countries that have the greatest number of publications from 2013 to 2023 obtained using the search term “nanoparticles AND veterinary” in the Lens.org database (accessed on 17 May 2023).

References

    1. Nanotechnologies—Vocabulary—Part 1: Core Terms. ISO (The International Organization for Standardization); Geneva, Switzerland: 2015.
    1. Kreuter J. Nanoparticles—A historical perspective. Int. J. Pharm. 2007;331:1–10. doi: 10.1016/j.ijpharm.2006.10.021. - DOI - PubMed
    1. Nanotechnologies—Vocabulary—Part 2: Nano-Objects. ISO (The International Organization for Standardization); Geneva, Switzerland: 2015.
    1. Mitchell M.J., Billingsley M.M., Haley R.M., Wechsler M.E., Peppas N.A., Langer R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 2021;20:101–124. doi: 10.1038/s41573-020-0090-8. - DOI - PMC - PubMed
    1. Heikkilä A.-M., Liski E., Pyörälä S., Taponen S. Pathogen-specific production losses in bovine mastitis. J. Dairy Sci. 2018;101:9493–9504. doi: 10.3168/jds.2018-14824. - DOI - PubMed

LinkOut - more resources